Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Polaris Health Directions

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Polaris Awarded $1.1 Million NIDA Grant to Improve Patient Engagement in Treatment for Addiction - Patient engagement is a critical component to successful outcomes in substance abuse treatment. With funding from NIDA, Polaris has developed a tool designed to predict and improve the likelihood of engagement
Polaris Awarded $1.1 Million NIDA Grant to Improve Patient Engagement in Treatment for Addiction

 

PRZOOM - /newswire/ - Langhorne, PA, United States, 2014/04/03 - Patient engagement is a critical component to successful outcomes in substance abuse treatment. With funding from NIDA, Polaris has developed a tool designed to predict and improve the likelihood of engagement.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Substance abuse has long been one of the greatest challenges facing health care systems. More patients drop out of treatment than complete it. And those who dropout are at greater risk of relapsing caught in a cycle with steep human and monetary costs.

With a $1.1 million, two year grant from the National Institute on Drug Abuse, Polaris Health Directions will launch in April the second phase of a project set to dramatically impact addictions outcomes.

Polaris will implement a cloud-based clinical system designed to predict and improve the likelihood of patient engagement in 12 addictions treatment programs of a large behavioral health system. The evidence-based, patient engagement predictive model is the first ever developed for clinical use.

The Polaris Engagement Enhancement for Chemical Dependency System, EECD for short, is an advanced version of Polaris CD, Polaris’s outcomes management system for substance abuse treatment and a leading example of translating research into practice. It is a data-driven solution to help clinicians develop treatment plans that directly reflect the needs patients have reported, determine whether the current course of treatment is effective and red flag those patients who are likely to dropout or relapse.

EECD extends the innovations of Polaris CD. The predictive model helps clinicians identify early those patients who are unlikely to engage in treatment. Additional enhancements include a motivational, personalized patient feedback report and a clinical report that provides guidance for Motivational Interviewing, a method known to be effective for improving engagement.

“The importance of patient engagement during substance abuse treatment cannot be overstated,” said Grant Grissom, Ph.D., president of Polaris. “Equipping clinicians with a validated tool that allows for earlier identification of at-risk patients and an evidence-based method for motivating them will improve engagement. Better engagement will mean better outcomes, including reduced relapse rates and the human and economic costs associated with it.”

The new components were successfully developed with data from the New Hope Foundation, one of New Jersey’s largest addiction treatment centers. A prototype was field tested at New Hope during phase one.

In phase two, data from about 10,000 patients will be used to study the effectiveness of EECD for improving engagement and lowering the rate of patients re-entering treatment within six months.

“We are very excited to start phase two of the EECD project,” said Tony Comerford, Ph.D., president and CEO of New Hope, and a consultant for phase two. “The potential for the instrument looks extremely promising. During phase one, we saw no-show rates for treatment drop 14 percent from the previous year, and counselors found the reports helpful to their work.”

Experts on motivational enhancement therapy from Yale University continue their support and consulting services for this highly significant project.

The project described was supported by Award Number 2R44DA032180-02 from the National Institute on Drug Abuse. The content is solely the responsibility of Polaris Health Directions and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.

About Polaris Health Directions

Polaris Health Directions (polarishealth.com) has been a pioneer in the development of behavioral health outcomes management solutions for nearly two decades. Using innovative technology, Polaris's cloud-based systems capture the information essential for determining the best course of care. Their advanced analytics help organizations execute quality improvement initiatives, identify cost reduction opportunities and, in many cases, indicate whether a particular course of treatment is likely to have a positive result. Systems are available for a wide range of health care settings; all support interdisciplinary coordination. By recognizing the nexus between psychosocial health and physical health, Polaris offers powerful solutions for better health care delivery.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Polaris Health Directions

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Polaris Awarded $1.1 Million NIDA Grant to Improve Patient Engagement in Treatment for Addiction

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Jesse Nankin - PolarisHealth.com 
215-359-3901 moreinfo[.]polarishealth.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Polaris Health Directions securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Polaris Health Directions / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market
Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey
US Acute Care Solutions Celebrates 2-Year Anniversary
GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with Coronary CT Angiography
Telehealth Vendors Expand mHealth Portfolio to Conquer New Growth Opportunities Finds Frost & Sullivan
GE Healthcare Acquires Asymptote for Complete, Digitally-enabled Cryogenic Cold Chain Technology Supporting Safe Manufacture And Delivery Of Cellular
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil
GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Persistence Market Research (P) Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today